Research


July 24, 2020

Grant Gives UAMS Physician-Scientist Access to Gene Analysis Software

Susan Van Dusen

Dr. Analiz Rodriguez

New grant funding will assist UAMS physician-scientist Analiz Rodriguez, M.D., Ph.D., in identifying more effective therapies for patients whose cancer has spread to their brain.


July 23, 2020

Fenghuang “Frank” Zhan, M.D., Ph.D., Awarded Nearly $3.14 Million to Further Myeloma Research

Linda Haymes

Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer.

LITTLE ROCK — Fenghuang “Frank” Zhan, M.D., Ph.D., Myeloma Center research director at the University of Arkansas for Medical Sciences (UAMS), has received two grants totaling almost $3.14 million to study the molecular genetics and drug resistance of multiple myeloma, the second-most common blood-related cancer. One grant from the U.S. Department of Defense provides $1.4…


July 16, 2020

UAMS Contributes to Global Study Published in Lancet on Lung Complications for COVID-19 Patients Undergoing Surgery

Amy Widner

Dr. Giorgakis posing for photo outside

COVID-19 patients who underwent surgery were more likely to develop lung complications or die compared to those without COVID-19 in an international study that included the University of Arkansas for Medical Sciences (UAMS) as a collaborating partner. Because of this heightened risk, the threshold for surgery should be higher during the pandemic, with consideration given…


June 17, 2020

Research Finds Inflammatory Connection for High Cholesterol, Suggests Possible Combo of Medications

Amy Widner

Portrait of Metha and Ding outside

New research at the University of Arkansas for Medical Sciences (UAMS) and the affiliated VA Medical Center suggests a combination of drug therapies – one that already exists and a second that would need to be developed to target a specific inflammatory response – could be effective for managing high LDL-cholesterol and atherosclerosis, and the…


June 10, 2020

UAMS-UA Research Yields Long-lasting Disinfectant Spray for Surfaces

Amy Widner

Portrait of Dr. Crooks

Researchers at UAMS and University of Arkansas, Fayetteville, are developing a long-lasting spray that coats and disinfects surfaces for extended periods, even in heavy use, and is less likely to transmit infectious diseases. The project is one of many at both campuses that uses research funding quickly made available during the COVID-19 pandemic for projects…


June 3, 2020

Findings on DNA Damage Repair Published by UAMS Cancer Researcher

Susan Van Dusen

Leung research team

A research team led by cancer researcher Justin Leung, Ph.D., at the University of Arkansas for Medical Sciences (UAMS) has uncovered the role of the protein RNF168 in DNA damage repair and shown how mutations of the protein affect people with a rare genetic condition.


May 21, 2020

UAMS Researcher to Use $991,000 to Improve Health of Arkansans with Food Insecurity and Type 2 Diabetes

David Wise

Chris Long

FAYETTEVILLE – A University of Arkansas for Medical Sciences (UAMS) researcher recently received a $991,145 grant from the U.S. Department of Agriculture (USDA) to study the nutritional health of low-income individuals with type 2 diabetes. Christopher Long, Ph.D., an assistant professor in the Department of Psychiatry, will use the  award from the USDA’s National Institute…


May 12, 2020

Arkansas INBRE Receives 5-Year Funding of $18.4 Million to Promote Biomedical Research Across Arkansas

Amy Widner

Group portrait of INBRE students

Arkansas INBRE, which promotes biomedical research with programs for undergraduate students and faculty statewide, has seen its federal funding renewed for $18.4 million over the next five years. While the University of Arkansas for Medical Sciences (UAMS) is the lead institution, INBRE grants and programs have impacted nearly all colleges and universities in the state…


May 7, 2020

UAMS Receives FDA Authorization for Convalescent Plasma Use, Plus Partnerships for Statewide Access

Amy Widner

Gloved hands holding plasma viles

The Food and Drug Administration has authorized the use of convalescent plasma in Arkansas as an experimental treatment for COVID-19 with the University of Arkansas for Medical Sciences (UAMS) as the expanded access treatment program sponsor. With the authorization, UAMS Medical Center is able to use the treatment now without applying for FDA approval for…


May 6, 2020

UAMS Radiation Oncologist Awarded $1.86 Million National Cancer Institute Grant

Susan Van Dusen

Fen Xia, M.D., Ph.D.

A five-year grant of more than $1.86 million from the National Cancer Institute (NCI) to the University of Arkansas for Medical Sciences (UAMS) will fund research aimed at reducing long-term neurological damage caused by a common cancer treatment regimen.



Previous page Next page